Literature DB >> 12199381

Treatment of talar osteochondral lesions using local osteochondral graft.

G James Sammarco1, Nilesh K Makwana.   

Abstract

Twelve patients with an osteochondral lesion of the talus were treated with excision of the lesions and local osteochondral autogenous grafting. The lesion was accessed through a replaceable bone block removed from the anterior tibial plafond. The graft was harvested from the medial or lateral talar articular facet on the same side of the lesion. The average age of the patients was 41 years and duration of symptoms was 90 months (ave.). There were six males and six females with the right talus involved in eight and the left in four patients. Graft sizes ranged from four to eight millimeters in diameter. There was a significant improvement in the AOFAS score from 64.4 (ave.) pre-operatively to 90.8 (ave.) postoperatively (p<0.0001), at a follow-up of 25.3 months (ave.). The AOFAS score was slightly higher in patients under 40 years of age and in those without pre-existing joint arthritis. All patients were very satisfied with the procedure. Arthroscopy performed in two patients at six and 12 months following surgery showed good graft incorporation. No complications occurred at the donor site or the site of bone block removal on the distal tibia. The results show that stage III and IV talar osteochondral lesions can be accessed successfully excising a tibial bone block and using local autogenous osteochondral graft harvested from the ipsilateral talar articular facet.

Entities:  

Mesh:

Year:  2002        PMID: 12199381     DOI: 10.1177/107110070202300803

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  24 in total

1.  Comparison of clinical outcomes between arthroscopic subchondral drilling and microfracture for osteochondral lesions of the talus.

Authors:  Jun-Ik Choi; Keun-Bae Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-04       Impact factor: 4.342

2.  CORR Insights®: Knee-to-Talus Donor-Site Morbidity Following Autologous Osteochondral Transplantation: A Meta-analysis with Best-case and Worst-case Analysis.

Authors:  Mark A Slabaugh
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

3.  Treatment of osteochondral lesions of the talus in athletes: what is the evidence?

Authors:  Francesca Vannini; Giuseppe Gianluca Costa; Silvio Caravelli; Gherardo Pagliazzi; Massimiliano Mosca
Journal:  Joints       Date:  2016-08-18

4.  Autologous osteochondral transplantation for osteochondral lesions of the talus in an athletic population.

Authors:  Ethan J Fraser; Mark C Harris; Marcelo P Prado; John G Kennedy
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-12       Impact factor: 4.342

5.  Arthroscopic microfracture for osteochondral lesions of the talus.

Authors:  Keun-Bae Lee; Long-Bin Bai; Jae-Yoon Chung; Jong-Keun Seon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-09-25       Impact factor: 4.342

6.  [Microfracture technique for the treatment of articular cartilage lesions of the talus].

Authors:  C Becher; A Driessen; H Thermann
Journal:  Orthopade       Date:  2008-03       Impact factor: 1.087

Review 7.  Cartilage repair techniques of the talus: An update.

Authors:  Mike H Baums; Wolfgang Schultz; Tanja Kostuj; Hans-Michael Klinger
Journal:  World J Orthop       Date:  2014-07-18

8.  Indications and limitations of osteochondral autologous transplantation in osteochondritis dissecans of the talus.

Authors:  Julia V Woelfle; H Reichel; M Nelitz
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-04-04       Impact factor: 4.342

9.  A soccer player with idiopathic osteonecrosis of the complete lateral talar dome: a case report.

Authors:  Job N Doornberg; Peter A J de Leeuw; Maartje Zengerink; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-05-07       Impact factor: 4.342

Review 10.  Treatment of osteochondral lesions of the talus: a systematic review.

Authors:  Maartje Zengerink; Peter A A Struijs; Johannes L Tol; Cornelis Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-27       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.